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Abstract
Background: To investigate the incidence and risk factors of glaucoma in normal-tension glaucoma (NTG) suspect
patients who had been lost-to-follow-up for at least 24 months.
Methods: Seventy-two eyes of 72 NTG suspect patients who returned to the hospital after at least 24 months of
follow-up loss were enrolled in this study between January 2009 and June 2013. The data were collected retrospectively.
The incidence of glaucoma was investigated using a comprehensive glaucoma evaluation in lost-to-follow-up NTG
suspect patients. The patients were classified into the glaucoma group, who developed glaucoma during the study
period, and the glaucoma suspect group, who did not, to analyse the risk factors for glaucoma.
Results: The number of patients who developed glaucoma was 7 (9.7 %) out of the 72 NTG suspect patients who had
been mean lost-to-follow-up for 44 months. The rate of progression from suspected to glaucoma was 2.6 %/year. In the
glaucoma group, the baseline intraocular pressure (IOP) was 18.43 ± 2.44 mmHg, and the average retinal nerve fiber
layer (RNFL) thickness was 78.14 ± 7.60 μm; in the glaucoma suspect group, the baseline IOP was 14.95 ± 2.47 mmHg,
and the average RNFL thickness was 92.55 ± 7.65 μm. The study results showed that the glaucoma group had higher
baseline IOP and a thinner average RNFL (p = 0.003; p < 0.001). The results of the multivariable logistic regression analysis
showed that the risk factors for glaucoma were high baseline IOP (OR = 1.63; p = 0.037) and a thin average RNFL
(OR = 0.841; p = 0.004).
Conclusions: The incidence of glaucoma in the lost-to-follow-up NTG suspect patients was 9.7 % for approximately
44 months, at a rate of 2.6 %/year. The risk factors for glaucoma in these patients were high baseline IOP and a thin
average RNFL.
Keywords: Loss to follow-up, Normal-tension glaucoma, Glaucoma suspect, Incidence, Risk factors, Baseline IOP, Retinal
nerve fiber layer
Background
Glaucoma is a major disease that causes irrecoverable
blindness worldwide [1]. Early detection and appropriate
treatment are essential to preventing blindness due to
glaucoma. Health check-ups and surgeries for visual acu-
ity correction have been more common recently, and
people have shown more interest in glaucoma, which
has led to an increased incidence of the disease. When
patients show a suspicious glaucomatous optic disc
during tests for visual acuity correction surgery or
during regular check-ups, they are referred to larger
hospitals for more detailed tests to diagnose glaucoma.
A “glaucoma suspect” is a person who has not yet devel-
oped glaucoma but has a risk of developing it in the fu-
ture, characterized by consistently high IOP or abnormal
optic disc, RNFL, or visual field test results that indicate
suspected glaucoma [2]. Glaucoma is characterized by a
morphological change in the optic disc and a subsequent
functional change in visual field loss; therefore, the
changes that may indicate glaucoma are followed up in
glaucoma suspect patients for diagnosis confirmation.
These patients must be followed up due to their risk of
developing glaucoma, but they are often lost-to-follow-
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up because most do not manifest any symptoms or do
not recognize the importance of follow-up observation
and the seriousness of the disease. Most of the past
large-scale epidemiological studies in populations esti-
mated the risk of glaucoma [3–7], and some studies have
investigated the incidence of glaucoma in ocular hyperten-
sion patients [8–11], but no study has been conducted to
investigate the incidence of glaucoma in normal tension
glaucoma (NTG) suspect patients. In this study, it was
study of patients with normal tension, NTG suspect was
defined as one with 21 mmHg or less IOP and with glau-
comatous optic disc findings on the normal visual field
test. Seventy-seven per cent of the South Korean patients
with primary open-angle glaucoma (POAG) can be con-
sidered NTG [7]. As such, more studies are required on
NTG suspect patients who show a high incidence of NTG
in the South Korean population. No study has been con-
ducted on the incidence and risk factors of glaucoma in
lost-to-follow-up NTG suspect patients. As such, this
study was conducted to analyse the incidence and risk
factors of glaucoma in NTG suspect patients who had
been recommended for follow-up observations without
treatment but with whom contact had been lost for at
least 24 months and who later returned to the hospital.
Methods
The study protocol was reviewed and approved by the
Institutional Review Board of the Nune Eye Hospital. It
also strictly adhered to the principles of the Declaration
of Helsinki. All subjects signed informed consent forms
prior to participation.
Study design and patients
A retrospective study was conducted using the medical
records of 72 patients who visited the Nune Eye Hospital
Glaucoma Centre between January 2009 and June 2013,
who were diagnosed as NTG suspect patients, and who
were recommended for follow-up observations without
treatment, but were lost-to-follow-up for at least 24
months and later revisited the hospital. The subjects’
follow-up loss period, sex, age, glaucoma family history,
and accompanying systemic disease (diabetes, hyperten-
sion) were recorded. All subjects underwent slit lamp
examination for anterior segment, funduscopy, and IOP
measurement using a Goldmann applanation tonometer,
the manifest refraction test, central corneal thickness
(CCT) measurement, optic disc stereophotography, RNFL
photography, the SITA 30-2 visual field test using an auto-
matic field analyser (Humphrey Field Analyzer II; Carl
Zeiss Meditec, Dublin, CA, USA), and average RNFL
thickness measurement with optical coherence tomog-
raphy (OCT; Cirrus HD-OCT; Carl Zeiss Meditec,
Dublin, CA, USA). The subjects who showed a best cor-
rected visual acuity of 20/30 or greater, a spherical
equivalent within ±6 diopter, and normal anterior segment
and gonioscopy findings were enrolled in the study.
Angle-closure glaucoma suspect patients are also consid-
ered glaucoma suspect patients in broad terms, but only
open-angle glaucoma suspect patients with normal ten-
sion were included in this study. The patients who had
ocular or neurological disorders other than glaucoma that
could have affected their visual fields, who had undergone
refractive surgery, and who had undergone any test for
glaucoma during the lost-to-follow-up period in another
hospital were excluded from this study. If both eyes were
eligible for the study, one eye was randomly selected.
Definitions
A NTG suspect was defined as one with 21 mmHg or
less IOP measured two times or more using a Goldmann
applanation tonometer and with glaucomatous optic disc
findings on the normal visual field test. A glaucomatous
optic disc is defined as one with a 0.6 or greater vertical
cup/disc ratio (VCDR) or a 0.2 or greater difference in
the VCDR between the eyes, minimal neural rim width
<0.1 times the disc diameter or RNFL damage around
the optic disc on stereophotography. Glaucoma was di-
agnosed if a subject showed glaucomatous visual field
loss with this glaucomatous optic disc. Glaucomatous
visual field loss was adjudged to exist when the thresh-
old of three or more adjacent dots in a pattern deviation
plot was 5 % or less compared with the normal, when
that of one or more of the three was 1 % or less, or
when that of two adjacent dots was 1 % or less on the
visual field test using a Humphrey visual field analyser.
In addition, findings outside of the normal limit or a 5 %
or less pattern standard deviation (PSD) compared with
the normal in the glaucoma hemifield test (GHT) were
also equated with glaucomatous visual loss. For the vis-
ual field test, a fixation loss of 20 % or less and false neg-
atives or positives of 15 % or less based on the reliability
indices were included in the analysis. The RNFL was
measured using the fast RNFL mode of OCT, and the
average RNFL thickness results were used for the ana-
lysis. The OCT images with a signal strength of 6 or
above with the optic disc in the centre of the scan circle
were considered reliable and were included in the ana-
lysis. The average value of the three measurements of
the CCT was used for the analysis. The baseline IOP
was the highest IOP without using any anti-glaucoma
medication at first diagnosed as NTG suspect. For the
other tests index, the conventional glaucoma evaluations
that were performed on the last hospital visit dates be-
fore follow-up loss were used as the baseline values. The
same tests were performed upon the subjects’ hospital
revisits to obtain the incidence of glaucoma. All test re-
sults were evaluated by two glaucoma specialists (J.H.L.
and S.Y.L.) after analysis, and any disagreements were
Lim et al. BMC Ophthalmology  (2016) 16:62 Page 2 of 7
settled via discussion; when necessary, an additional grader
(Y.J.H) was consulted.
Statistical analysis
Statistical analysis was conducted using SPSS for
Windows ver. 21.0 (SPSS Science, Chicago, IL, USA). The
subjects were classified as glaucoma or glaucoma suspect
depending on the development of glaucoma. The follow-
up loss period, age, baseline IOP, mean deviation (MD),
PSD, average RNFL thickness, VCDR, CCT, and spherical
equivalent of the two groups were compared using the
Mann-Whitney U-test. The chi-square test was used to
compare the subjects’ sexes, glaucoma family histories,
and accompanying diabetes or hypertension, optic nerve
head (ONH) characteristics. Univariable logistic regression
analysis was performed to analyse the risk factors for glau-
coma, and the factors with p < 0.1 underwent multivari-
able logistic regression analysis. P < 0.05 was considered
statistically significant.
Results
There were 72 NTG suspect patients who revisited the
hospital after at least 24 months of follow-up loss. Of
these, 28 (38.9 %) were males and 44 (61.1 %) were fe-
males. Their mean age was 44.47 ± 12.25 years old
(range: 20-73), and their mean lost-to-follow-up period
was 44.76 ± 13.54 months (range: 25–84 months). Nine
subjects (12.5 %) had a family history of glaucoma, and 4
(5.6 %) and 7 (9.7 %) subjects had accompanying dia-
betes and hypertension, respectively (Table 1). The mean
baseline IOP was 15.29 ± 2.66 mmHg (range: 11–21
mmHg). The mean MD and PSD based on the visual
field test were −0.88 ± 1.18 dB (range: -3.10 ~ 1.99 dB)
and 1.54 ± 0.34 dB (range: 0.91–2.70 dB), respectively.
The mean average RNFL thickness based on OCT was
91.15 ± 8.72 μm (range: 69–111 μm). The mean VCDR
was 0.67 ± 0.06 (range: 0.50–0.90). The mean CCT and
spherical equivalent were 560.32 ± 31.28 μm (range:
495–633 μm) and -1.49 ± 2.14D (range: -5.88 ~ +2.50D),
respectively. We were evaluated the characteristics of
ONH by stereophotography, the results are shown as a
table (Table 2).
The number of patients who developed glaucoma among
the 72 NTG suspect patients who had been lost-to-follow-
up at least 24 months in this study was 7 (9.7 %). The rate
of progression from NTG suspect to glaucoma was
2.6 %/year. The mean baseline IOP in the glaucoma
group was 18.43 ± 2.44 mmHg (range: 16–21 mmHg),
and that of the glaucoma suspect group was 14.95 ±
2.47 mmHg (range: 11–20 mmHg), showing a signifi-
cantly higher mean baseline IOP in the glaucoma
group (p = 0.003). The average RNFL thickness was
78.14 ± 7.60 μm (range: 70–88 μm) in the glaucoma
group and 92.55 ± 7.65 μm (range: 69–111 μm) in the
glaucoma suspect group, showing that the glaucoma
group had significantly thinner RNFLs (p < 0.001).
The mean lost-to-follow-up period was 49.14 ± 10.90
months (range: 34–67 months) in the glaucoma group
and 44.29 ± 13.79 months (range: 25–84 months) in
the glaucoma suspect group, showing no statistically
significant difference between the groups (p = 0.199).
No significant differences were shown in either age,
sex, glaucoma family history, accompanying diabetes
or hypertension, MD, PSD, VCDR, CCT, or spherical
equivalent, ONH characteristics between the groups
(p > 0.05) (Table 3).
Univariable logistic regression analysis was performed
to investigate the risk factors that NTG suspect patients
Table 1 Demographics of lost-to-follow-up NTG suspect patients
Parameter Total (n = 72 patients)
Sex (M:F) (n, %) 28:44 (38.9:61.1)
Age (years) 44.47 ± 12.25




Over 61 8 (11.1)
Loss to follow-up period (months) 44.76 ± 13.54
Glaucoma family history (n, %) 9 (12.5)
Past medical history (n, %)
Diabetes mellitus 4 (5.6)
Hypertension 7 (9.7)
Values are presented as mean ± SD unless otherwise indicated
Table 2 Clinical baseline characteristics of lost-to-follow-up NTG
suspect patients
Clinical characteristics Total (n = 72 eyes)
Baseline IOP (mm Hg) 15.29 ± 2.66
MD (dB) −0.88 ± 1.18
PSD (dB) 1.54 ± 0.34
Average RNFL thickness (μm) 91.15 ± 8.72
Mean VCDR 0.67 ± 0.06
Central corneal thickness (μm) 560.32 ± 31.28
Refractive error (SE, diopter) −1.49 ± 2.14
ONH characteristics (n, %)
VCDR≥ 0.6 48 (66.6)
VCDR asymmetry≤ 0.2 7 (9.7)
Neural rim thinning 11 (15.3)
Focal RNFL defect 3 (4.2)
Diffuse RNFL defect 3 (4.2)
Values are presented as mean ± SD unless otherwise indicated
IOP intraocular pressure, MD mean deviation, PSD pattern standard deviation,
RNFL retinal nerve fiber layer, VCDR vertical cup/disc ratio, SE spherical
equivalent, ONH optic nerve head
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would progress to glaucoma, and the results showed sta-
tistically significant differences between the groups in
baseline IOP (p = 0.005) and average RNFL thickness
(p = 0.001). In the results of the univariable logistic
regression analysis, the factors with p < 0.1 further
underwent multivariable logistic regression analysis of
the relationships. Higher baseline IOP (OR = 1.63; 95 %
CI: 1.03–2.57; p = 0.037) and thinner average RNFL
(OR = 0.84; 95 % CI: 0.75–0.95; p = 0.004) were shown
to be significant risk factors for glaucoma in NTG
suspect patients (Table 4).
Discussion
The term “glaucoma suspect” was advocated by Shaffer
[12] and refers to a person with high IOP (over 21
mmHg) or an abnormal optic disc, RNFL, or visual field
test results or findings [2]. A glaucoma suspect patient
has not yet developed glaucoma but has the risk of de-
veloping it in the future. As such, continuous follow-up
is required for the early detection of glaucoma. In an
ocular hypertension treatment study (OHTS), 89 (10.9
%) of the 819 untreated ocular hypertension patients
developed glaucoma at the rate of 2 %/year over 5 years
[9]. Kitazawa et al. [13] conducted a study in a Japanese
population and reported that 7 (9.3 %) of the 75 untreated
ocular hypertension patients in their study developed
glaucoma over 9 years. The incidences of progression
from ocular hypertension to glaucoma varied, ranging
from 0 to 35.9 %, which was considered to be related to
the different subjects, observation periods, and definitions
of glaucoma [8]. Kim et al. [11] reported that in their
study, 24 (23.7 %) of the 101 POAG suspect patients de-
veloped glaucoma at the rate of 4.75 %/year over 5 years
based on the health check-up data that they obtained. The
present study was the first to have enrolled NTG suspect
patients, and the study results showed that the incidence
of glaucoma in the lost-to-follow-up NTG suspect pa-
tients was 7 of 72 subjects (9.7 %) over a 44-month
follow-up loss period with a rate of 2.6 %/year. This rate
was slightly lower than those in the previous studies that
reported 3–5 %/year rates in high-risk glaucoma suspect
patients [14–16]. Compared with the 0.1 %/year rate of
progression to glaucoma in normal subjects based on the
Melbourne Visual Impairment Project [3] and a rate of
Table 3 Characteristics of lost-to-follow-up NTG suspect patients divided into two groups by developing glaucoma (glaucoma vs.
glaucoma suspect)
Characteristics Glaucoma Suspected glaucoma p-value
(n = 7; 7 eyes) (n = 65; 65 eyes)
Sex (M:F) (n, %) 5:2 (71.4:28.6) 23:42 (35.4:64.6) 0.063a
Age (years) 45.00 ± 13.09 44.42 ± 12.26 0.894b
Loss to follow-up period (months) 49.14 ± 10.90 44.29 ± 13.79 0.199b
Glaucoma family history (n, %) 2 (28.6) 7 (10.8) 0.176a
Past medical history (n, %)
Diabetes mellitus 1 (14.3) 3 (4.6) 0.289a
Hypertension 1 (14.3) 6 (9.2) 0.668a
Baseline IOP (mm Hg) 18.43 ± 2.44 14.95 ± 2.47 0.003b,*
MD (dB) −1.01 ± 0.84 −0.87 ± 1.21 0.704b
PSD (dB) 1.68 ± 0.39 1.53 ± 0.34 0.296b
Average RNFL thickness (μm) 78.14 ± 7.60 92.55 ± 7.65 <0.001b,*
VCDR 0.67 ± 0.05 0.67 ± 0.07 0.774b
Central corneal thickness (μm) 557.00 ± 35.15 560.68 ± 31.11 0.887b
Refractive error (SE, diopter) −3.06 ± 2.44 −1.32 ± 2.06 0.090b
ONH characteristics (n, %)
VCDR≥ 0.6 3 (42.8) 45 (69.2) 0.160a
VCDR asymmetry≤ 0.2 0 (0.0) 7 (10.8) 0.361a
Neural rim thinning 2 (28.6) 9 (13.8) 0.304a
Focal RNFL defect 1 (14.3) 2 (3.1) 0.159a
Diffuse RNFL defect 1 (14.3) 2 (3.1) 0.159a
Values are presented as mean ± SD unless otherwise indicated
IOP intraocular pressure, MD mean deviation, PSD pattern standard deviation, RNFL retinal nerve fiber layer, VCDR vertical cup/disc ratio, SE spherical equivalent,
ONH optic nerve head
*p < 0.05 was considered significant
aChi-square test; bMann-Whitney U-test
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0.55 %/year based on the Barbados Eye Study [4], the
results in the present study were relatively greater.
The early detection of progression from glaucoma sus-
pect to glaucoma patient requires regular observations.
The American Academy of Ophthalmology recommends
follow-up every 3–24 months depending on the patient’s
risk of developing glaucoma [2]. The European Glaucoma
Society also recommended follow-up every 6–12 months
[17]. This study was performed in patients who had been
lost-to-follow-up for at least 24 months. The mean lost-
to-follow-up period was longer in the glaucoma group
(49.14 months) than in the glaucoma suspect group (44.29
months), but the difference was not statistically significant.
As the lost-to-follow-up period increases, patients age,
and the incidence of glaucoma generally increases. As
such, longer lost-to-follow-up periods will unfavourably
affect the early detection of glaucoma.
Glaucoma suspect patients’ risk of developing glaucoma
is known to increase with the intensity and number of risk
factors [8]. The OHTS [9] and European Glaucoma Pre-
vention Study (EGPS) [10] are typical studies on the pro-
gression from ocular hypertension to glaucoma. In both
studies, high IOP, older age, thin CCT, and high PSD are
considered risk factors for glaucoma. In the EGPS, a
greater VCDR is considered a glaucoma risk factor. In
addition, some studies reported the shape of the optic
nerve, myopia, and a family history of glaucoma as risk
factors for glaucoma in ocular hypertension [18–20]. Kim
et al. [11] suggested that old age, high baseline IOP, high
BMI, high level of education, and high hematocrit level
were risk factors for glaucoma for POAG suspect patients.
The results of the univariable logistic regression analysis
that was performed in this study to identify the risk factors
for glaucoma in NTG suspect patients showed that there
were statistically significant differences in baseline IOP
(OR = 1.74; p = 0.005) and in average RNFL thickness
(OR = 0.83; p = 0.005) between the glaucoma and glau-
coma suspect groups. Multivariable logistic regression
analysis was performed using the factors with p < 0.1 in
the univariable logistic regression analysis. The results also
showed that high baseline IOP (OR = 1.63; p = 0.037) and
a thin RNFL (OR = 0.84; p = 0.004) were significant risk
factors for glaucoma in NTG suspect patients.
The differences between the glaucoma risk factors iden-
tified in this study and those identified in the previous
studies were considered to be due to the different subject
groups, including different ethnicities; other differences
were attributed to selection bias, different diagnosis
methods, different definitions of glaucoma, different stat-
istical analysis methods, and differences in numbers of
subjects. Both the OHTS and the EGPS were conducted
in ocular hypertension patients, whereas this study was
conducted in NTG suspect patients. Old age was not con-
sidered a glaucoma risk factor in this study, although it
was considered to be so in many previous studies. This
finding was attributed to the relative youth (mean age:
44.47 years) of the subjects in this study and to the fact
that only 8 subjects (11.1 %) were 61 years old or older.
More systematic studies with a greater number of subjects
are required in the future.
High IOP was considered the most important risk factor
for glaucoma. Many previous studies on the incidence of
Table 4 Logistic regression analysis when the dependent variable was the presence of a glaucomatous change
Factors Univariable analysis Multivariable analysisa
OR (95 % CI) p-value OR (95 % CI) p-value
Male gender 4.57 (0.82–25.41) 0.083
Age (years) 1.00 (0.94–1.07) 0.904
Loss to follow-up period (months) 1.03 (0.97–1.08) 0.371
Glaucoma family history (n) 3.31 (0.54–20.41) 0.196
Past medical history (n)
Diabetes mellitus 3.44 (0.31–38.48) 0.315
Hypertension 1.64 (0.17–15.98) 0.671
Baseline IOP (mm Hg) 1.74 (1.19–2.56)b 0.005 1.63 (1.03–2.57)b 0.037
MD (dB) 0.90 (0.46–1.76) 0.750
PSD (dB) 3.08 (0.40–23.53) 0.279
Average RNFL thickness (μm) 0.83 (0.75–0.92) 0.001b 0.84 (0.75–0.95)b 0.004
VCDR 3.14 (0.00–47.13) 0.851
Central corneal thickness (μm) 1.00 (0.97–1.02)b 0.766
Refractive error (SE, diopter) 0.70 (0.49–1.00)b 0.053
OR odds ratio, CI confidence interval, IOP intraocular pressure, MD mean deviation, PSD pattern standard deviation, RNFL retinal nerve fiber layer, VCDR vertical
cup/disc ratio, SE spherical equivalent
aBackward elimination method; adjusted for all variables with p < 0.1 in the univariable model; bOR and 95 % CI with p < 0.05
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glaucoma indicated that patients with higher IOP showed
higher incidences of glaucoma [3–7]. In this study, the
baseline IOP was significantly higher in the glaucoma
group (18.43 mmHg) than in the glaucoma suspect group
(14.95 mmHg), and the results of the multivariable logistic
regression analysis showed that high baseline IOP was a
glaucoma risk factor in the NTG suspect group (OR =
1.63; p = 0.037), which was similar to the results of the
previous studies [9–11]. The role of IOP as part of the
NTG aetiology has been controversial, but the results of
this study support the important role of high IOP in
developing glaucoma.
In glaucoma, the RNFL of the optic nerve is known to
become progressively thinner with the loss of retinal
ganglion cells. Therefore, RNFL thickness is considered
important in the diagnosis and follow-up of the progres-
sion to glaucoma [21, 22]. Glaucoma shows a change in
the optic disc and RNFL prior to any functional damage,
such as changes in the visual field. It is known that de-
creased RNFL thickness comes before a change in the
optic disc [22–25]. One study reported that the mean
RNFL thickness among Koreans was 100.84 μm [26].
Hirasawa et al. [27] reported a mean RNFL thickness of
102 μm in 251 normal eyes of Japanese participants
measured using SD-OCT. The average RNFL thickness
in Asian populations has been reported to be 100 μm or
more [28]. This study showed an average RNFL thick-
ness of 91.15 μm in NTG suspect patients and showed
that the average RNFL thickness in the glaucoma group
(78.14 μm) was significantly thinner than that in the
glaucoma suspect group (92.55 μm). Furthermore, the
multivariable logistic regression analysis showed that a
thin average RNFL could be a risk factor for glaucoma
in NTG suspect patients (OR = 0.84; p = 0.004).
This study had some advantages compared with the pre-
vious population-based studies: (1) it was the first study
that was conducted in lost-to-follow-up NTG patients; (2)
it minimized investigator bias because the subjects were
lost-to-follow-up on their own volition; (3) various ocular
tests could be conducted because the study was hospital-
rather than population-based and, accordingly, the oph-
thalmological risk factors could be analysed.
This study, however, also had a number of limitations.
First, the data were analysed retrospectively using the
subjects’ medical records, and many of the data on loss
to follow-up were dependent on the subjects’ descrip-
tions, which made the data less objective. In addition,
the incidence of glaucoma requires the long-term inves-
tigation of an extensive population, but this study had a
limited number of subjects, and the lost-to-follow-up
period was too short for identifying glaucoma risk fac-
tors. Considering the conditions of subject enrolment,
however, only the patients who were diagnosed as NTG
suspects, who had been lost-to-follow-up for some time,
and who had revisited the hospital were enrolled in the
study, making it difficult to recruit subjects.
Conclusions
This study was conducted to identify the incidence and
risk factors of glaucoma in NTG suspect patients accord-
ing to the lost-to-follow-up period and to draw attention
to the implications of being lost-to-follow-up. In conclu-
sion, approximately 9.7 % of the lost-to-follow-up NTG
suspect cases in this study developed glaucoma over 44
months, and the progression rate was 2.6 %/year. This
result emphasizes the importance of regular follow-up ob-
servation through thorough patient training given that the
NTG suspect patients in this study showed a higher inci-
dence of glaucoma compared with the healthy partici-
pants. In addition, NTG suspect patients with confirmed
risk factors such as high baseline IOP and a thin average
RNFL should be more carefully observed.
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